Work

Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).

Year: 2020
Type: conference-abstract
Language: English
Field: Medicine
Open Access status: closed
OpenAlex ID: W3030280670
Cites:
Cited by: 70
Related to: 10